Patents Examined by Evelyn M. Huang
  • (1,2,3,4-tetrahydroquinolin-8-yl)-heptatrienoic acid derivatives having serum glucose reducing activity
    Patent number: 6734193
    Abstract: Compounds of the formula where the variables have the meaning defined in the specification are capable of reducing serum glucose levels in diabetic mammals without the undesirable side effects of reducing serum thyroxine levels and transiently increasing triglyceride levels.
    Type: Grant
    Filed: June 3, 2003
    Date of Patent: May 11, 2004
    Assignee: Allergan, Inc.
    Inventors: Tien Duong, Richard L. Beard, Roshantha A. Chandraratna